BODMER MARK (CSO, President of R&D) sold 10.9% of their position (3.16K shares) of EVELO BIOSCIENCES, INC. on the open market
Open‑market sale worth $1.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/8/2023ACC: 0001694665-23-000179
Officer· CSO, President of R&D
Since Jan 2019
-3.16K
Net shares
Net seller
$1.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.63K acquired · 9.79K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.63K
Price / share
—
Trade value
—
% of position
29.7%
11/7/2023
22.27K→28.89K
Common Stock
Direct
Shares
−3.16K
Price / share
$0.33
Trade value
$1.04K
% of position
10.9%
11/8/2023
28.89K→25.73K
Total
Net shares
+3.46K
Net value
-$1.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/7/2023 | M · Option Exercise | +6.63K | — | — | 29.7% | 22.27K | 28.89K |
| Common Stock Direct | 11/8/2023 | S · Sale | −3.16K | $0.33 | $1.04K | 10.9% | 28.89K | 25.73K |
| Total | +3.46K | -$1.04K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
6.63K shares
Shares
−6.63K
Strike price
Held after
6.63K
Exercisable
—
11/7/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock6.63K shares | 11/7/2023 | M · Option Exercise | −6.63K | — | 6.63K |